Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
- PMID: 35747141
- PMCID: PMC9210665
- DOI: 10.3389/fimmu.2022.952446
Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review
Abstract
[This corrects the article DOI: 10.3389/fimmu.2022.913464.].
Keywords: hepatic arterial infusion chemotherapy; hepatocellular carcinoma; immune checkpoint inhibitors; systematic review; transarterial chemoembolization; tyrosine kinase inhibitors.
Copyright © 2022 Ke, Xin, Fang, Zeng, Wang and Liu.
Erratum for
-
The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.Front Immunol. 2022 May 23;13:913464. doi: 10.3389/fimmu.2022.913464. eCollection 2022. Front Immunol. 2022. PMID: 35677059 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
